View Older Stories View More Recent Stories

Apr 5, 2016 08:22AM Pfizer (PFE), Merck (MRK) Treat First Patient in Avelumab Phase 3
Apr 5, 2016 08:10AM Pfizer (PFE), Merck KGaA Treat First Patient in Avelumab Phase 3 in RCC Setting
Apr 5, 2016 08:00AM Merck KGaA, Darmstadt, Germany, and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma
Apr 5, 2016 08:00AM Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma
Apr 5, 2016 07:04AM Pfizer (PFE) Announces Tofacitinib Phase 3 Met Primary Efficacy Endpoints in Psoriatic Arthritis
Apr 5, 2016 07:00AM Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis
Apr 1, 2016 08:01AM Pfizer (PFE) Announces Bococizumab Phase 3 SPIRE-AI Met co-Primary Endpoints
Apr 1, 2016 08:00AM Pfizer Announces Positive Topline Results from Second Phase 3 Lipid-Lowering Study Evaluating Bococizumab
Mar 30, 2016 12:42PM Pfizer (PFE), Allergan (AGN) Announce Receipt of FTC Request for Additional Info on Proposed Merger
Mar 30, 2016 12:41PM Pfizer and Allergan Receive Request for Additional Information from Federal Trade Commission Regarding Proposed Combination
Mar 30, 2016 07:46AM Pfizer (PFE), Bristol-Myers Squibb (BMY) Will Present 16 Abstracts at ACC.16
Mar 30, 2016 07:45AM Bristol-Myers Squibb and Pfizer Announce Global Real-World Data Program and Present New Analyses of Eliquis (apixaban) at the American College of Cardiology’s 65th Annual Scientific Session
Mar 23, 2016 04:15PM Pfizer's (PFE) MAA for XELJANZ Accepted for Review by EMA
Mar 23, 2016 04:15PM Pfizer Announces European Medicines Agency Accepted for Review Its Marketing Authorization Application for XELJANZ® (Tofacitinib Citrate) for the Treatment of Moderate to Severe Rheumatoid Arthritis
Mar 22, 2016 08:30AM Pfizer Joins The Human Vaccines Project To Help Decode The Immune System
Mar 18, 2016 11:01AM Pfizer's (PFE) Oral Tofacitinib Met Primary, Secondary Endpoints in Two Phase 3s
Mar 18, 2016 11:00AM Pfizer Announces Oral Tofacitinib, an Investigational JAK Inhibitor, Meets Primary and Key Secondary Endpoints in Two Pivotal Phase 3 Ulcerative Colitis Trials
Mar 16, 2016 08:08AM Pfizer (PFE) to Present New Data on Tofacitinib in UC and Crohn's Disease at ECCO
Mar 16, 2016 08:00AM Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO
Mar 15, 2016 01:53PM Pfizer Celebrates a Year of Achievements in 2015 Annual Review
Mar 11, 2016 01:12PM Pfizer (PFE) Announces XALKORI Approved by FDA for Treatment of Patients with ROS1-Positive Metastatic NSCLC
Mar 11, 2016 01:10PM XALKORI® (crizotinib) Approved by U.S. FDA for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer
Mar 9, 2016 08:00AM New Survey Reveals Many Living with Symptoms of Diabetic Nerve Pain Are Undiagnosed Despite Severe and Constant Pain
Mar 9, 2016 06:46AM Pfizer (PFE) Enters $5 Billion Accelerated Stock Buyback
Mar 9, 2016 06:45AM Pfizer Commences $5 Billion Accelerated Share Repurchase
Mar 3, 2016 07:15AM Merck, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Mar 3, 2016 07:07AM Pfizer (PFE), Merck KGaA, Verastem (VSTM) Collaborate to Evaluate Avelumab + VS-6063 Combo in Ovarian Cancer
Mar 3, 2016 07:00AM Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Feb 24, 2016 11:16AM Pfizer's (PFE) XELJANZ XR Extended-Release Tablets Approved by FDA
Feb 24, 2016 11:15AM Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis
Feb 19, 2016 04:36PM Pfizer (PFE) Reports Expanded FDA Approval For IBRANCE
Feb 19, 2016 04:35PM Pfizer Receives Expanded FDA Approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer
Feb 16, 2016 06:48AM Pfizer (PFE) Announces Wyeth Settlement Over Protonix-Related Rebating Claims
Feb 16, 2016 06:45AM WYETH REACHES AGREEMENT IN PRINCIPLE TO RESOLVE MEDICAID DRUG REBATE CLAIMS FOR 2001-2006 PERIOD FOR PROTONIX
Feb 9, 2016 06:57PM Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications
Feb 1, 2016 06:56AM Portola Pharma (PTLA) Enters Licensing Agreements for Investigational Agent Andexanet in Japan (BMY) (PFE)
Feb 1, 2016 06:55AM Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan
Jan 14, 2016 06:09AM Pfizer (PFE) Acquires Treerly Health from Sino Pharma
Jan 13, 2016 07:04PM Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma
Jan 8, 2016 04:14PM Pfizer (PFE) to Include Early-Stage Scientific Innovations in R&D Equity Investment Strategy
Jan 8, 2016 04:13PM Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations
Jan 4, 2016 09:02AM FuelCell Energy (FCEL) Plans 5.6MW Fuel Cell System for Pfizer (PFE)
Dec 21, 2015 04:01PM Pfizer's (PFE) Phase 3 Study of Pristiq in MDD Misses Primary Endpoint
Dec 21, 2015 04:00PM Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder
Dec 18, 2015 06:35AM ViiV Healthcare to Acquire Bristol-Myers Squibb's (BMY) Investigational HIV Medicines Pipeline
Dec 15, 2015 09:24AM Pre-Open Stock Movers 12/15: (KTOV) (LL) (VRX) Higher; (NEOT) (KMT) (ZOES) Lower (more...)
Dec 14, 2015 04:30PM Pfizer Declares First-Quarter 2016 Dividend
Dec 10, 2015 04:25PM Bristol-Myers Squibb (BMY) , Pfizer (PFE) Announce Encouraging Post-Hoc Data from Phase 3 AMPLIFY in VTE
Dec 10, 2015 04:15PM AMPLIFY Post-Hoc Early Time Course Analysis Evaluated Recurrent Venous Thromboembolism (VTE), VTE-Related Death and Major Bleeding in Deep Vein Thrombosis and Pulmonary Embolism Patients Treated with
Nov 30, 2015 02:00AM PureTech Names Scientific Advisory Board and Expands Senior Team
View More Recent Stories View Older Stories